Simplex Trading’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.52K | Hold |
200
| – | – | ﹤0.01% | 7950 |
|
|
2025
Q4 | $5.18K | Sell |
200
-300
| -60% | -$7.13K | ﹤0.01% | 7411 |
|
|
2025
Q3 | $12K | Buy |
500
+100
| +25% | +$2.46K | ﹤0.01% | 7765 |
|
|
2025
Q2 | $9K | Buy |
400
+200
| +100% | +$5.04K | ﹤0.01% | 7406 |
|
|
2025
Q1 | $4K | Sell |
200
-23,500
| -99% | -$563K | ﹤0.01% | 7710 |
|
|
2024
Q4 | $446K | Sell |
23,700
-1,900
| -7% | -$33.4K | ﹤0.01% | 3666 |
|
|
2024
Q3 | $385K | Buy |
25,600
+20,500
| +402% | +$350K | ﹤0.01% | 3868 |
|
|
2024
Q2 | $145K | Sell |
5,100
-7,400
| -59% | -$211K | ﹤0.01% | 4969 |
|
|
2024
Q1 | $365K | Buy |
12,500
+10,000
| +400% | +$307K | ﹤0.01% | 4178 |
|
|
2023
Q4 | $84K | Buy |
2,500
+1,800
| +257% | +$52.7K | ﹤0.01% | 5558 |
|
|
2023
Q3 | $21K | Buy |
+700
| New | +$25.2K | ﹤0.01% | 6583 |
|
|
2023
Q2 | – | Sell |
-400
| Closed | -$16K | – | 9688 |
|
|
2023
Q1 | $16K | Hold |
400
| – | – | ﹤0.01% | 7136 |
|
|
2022
Q4 | $15K | Buy |
+400
| New | +$19.5K | ﹤0.01% | 7159 |
|
|
2022
Q2 | – | Sell |
-7,400
| Closed | -$564K | – | 10797 |
|
|
2022
Q1 | $564K | Sell |
7,400
-2,400
| -24% | -$160K | ﹤0.01% | 3685 |
|
|
2021
Q4 | $589K | Buy |
9,800
+9,200
| +1,533% | +$507K | ﹤0.01% | 3581 |
|
|
2021
Q3 | $35K | Hold |
600
| – | – | ﹤0.01% | 7957 |
|
|
2021
Q2 | $36K | Buy |
600
+569
| +1,835% | +$36K | ﹤0.01% | 8043 |
|
|
2021
Q1 | $217K | Buy |
31
+30
| +3,000% | +$2.14K | ﹤0.01% | 4621 |
|
|
2020
Q4 | $5K | Buy |
+1
| New | +$59 | ﹤0.01% | 7726 |
|
|
2020
Q3 | – | Sell |
-32
| Closed | -$167K | – | 8301 |
|
|
2020
Q2 | $167K | Sell |
32
-76
| -70% | -$3.18K | ﹤0.01% | 4199 |
|
|
2020
Q1 | $362K | Buy |
108
+97
| +882% | +$4.03K | ﹤0.01% | 2940 |
|
|
2019
Q4 | $49K | Sell |
11
-124
| -92% | -$5.27K | ﹤0.01% | 5203 |
|
|
2019
Q3 | $513K | Buy |
135
+115
| +575% | +$4.59K | ﹤0.01% | 2595 |
|
|
2019
Q2 | $86K | Sell |
20
-14
| -41% | -$594 | ﹤0.01% | 4342 |
|
|
2019
Q1 | $129K | Buy |
34
+33
| +3,300% | +$1.29K | ﹤0.01% | 4076 |
|
|
2018
Q4 | $4K | Sell |
1
-790
| -100% | -$36.9K | ﹤0.01% | 6330 |
|
|
2018
Q3 | $3.89M | Buy |
791
+514
| +186% | +$22.2K | 0.01% | 770 |
|
|
2018
Q2 | $887K | Sell |
277
-231
| -45% | -$7.97K | ﹤0.01% | 1909 |
|
|
2018
Q1 | $170K | Buy |
508
+321
| +172% | +$11.4K | 0.01% | 1359 |
|
|
2017
Q4 | $33K | Buy |
187
+153
| +450% | +$6.06K | ﹤0.01% | 2832 |
|
|
2017
Q3 | $32K | Buy |
34
+2
| +6% | +$80 | ﹤0.01% | 2726 |
|
|
2017
Q2 | $3K | Sell |
32
-26
| -45% | -$1.21K | ﹤0.01% | 5001 |
|
|
2017
Q1 | $14K | Sell |
58
-58
| -50% | -$2.51K | ﹤0.01% | 3649 |
|
|
2016
Q4 | $83K | Buy |
116
+37
| +47% | +$1.24K | 0.01% | 1697 |
|
|
2016
Q3 | $70K | Sell |
79
-71
| -47% | -$2.78K | ﹤0.01% | 1822 |
|
|
2016
Q2 | $199K | Buy |
150
+94
| +168% | +$4.62K | 0.01% | 995 |
|
|
2016
Q1 | $51K | Buy |
56
+30
| +115% | +$1.75K | ﹤0.01% | 1935 |
|
|
2015
Q4 | $3K | Sell |
26
-53
| -67% | -$3K | ﹤0.01% | 4272 |
|
|
2015
Q3 | $181K | Buy |
79
+17
| +27% | +$1.04K | 0.01% | 981 |
|
|
2015
Q2 | $27K | Buy |
62
+47
| +313% | +$3.7K | ﹤0.01% | 2196 |
|
|
2015
Q1 | $17K | Sell |
15
-5
| -25% | -$507 | ﹤0.01% | 2467 |
|
|
2014
Q4 | $6K | Buy |
+20
| New | +$1.89K | ﹤0.01% | 2971 |
|
Other funds holding PCRX
DPCM
VPM
VCM
Simplex Trading's PCRX Position: Q1 2026 in Review
Simplex Trading opened a new position in Pacira BioSciences (PCRX) in Q1 2026: 56 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #8520 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PCRX as recently as Q2 2025.
Simplex Trading first reported a position in PCRX in Q3 2015 and has held it in 22 quarters since. The position peaked at $1.43M in Q4 2018. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.
- Simplex Trading held 56 shares of Pacira BioSciences worth $1.26K as of Q1 2026.
- Pacira BioSciences was a new Simplex Trading position in Q1 2026.
- Pacira BioSciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8520 holding.
- Simplex Trading first reported a position in Pacira BioSciences in Q3 2015 and has held it in 22 quarters since.
- Simplex Trading's Pacira BioSciences position peaked at $1.43M in Q4 2018.
- 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.